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Abstract Transcription factors have been studied as an im-
portant drug candidate. Ever since the successful generation of
induced pluripotent stem cells (iPSCs), there has been tremen-
dous interest in reprogramming transcription factors. Because
of the safety risks involved in a virus-based approach, many
researchers have been trying to deliver transcription factors
using nonintegrating materials. Thus, delivery of transcription
factors produced as recombinant proteins in E. coli was pro-
posed as an alternative method. However, the low level of
soluble expression and instability of such recombinant pro-
teins are potential barriers. We engineered a Bombyx mori
30Kc19 protein as a fusion partner for transcription factors
to overcome those problems.We have previously reported that
30Kc19 protein can be produced as a soluble form in E. coli
and has a cell-penetrating property and a protein-stabilizing
effect. Transcription factors fused with 30Kc19 (Oct4-
30Kc19, Sox2-30Kc19, c-Myc-30Kc19, L-Myc-30Kc19,
and Klf4-30Kc19) were produced as recombinant proteins.
Interestingly, Oct4 and L-Myc were expressed as a soluble
form by conjugating with 30Kc19 protein, whereas Oct4
alone and L-Myc alone aggregated. The 30Kc19 protein also
enhanced the stability of transcription factors both in vitro and
in cells. In addition, 30Kc19-conjugated transcription factors
showed rapid delivery into cells and transcriptional activity
significantly increased. Overall, 30Kc19 protein conjugation
simultaneously enhanced soluble expression, stability, and
transcriptional activity of transcription factors. We propose
that the conjugation with 30Kc19 protein is a novel approach
to solve the technical bottleneck of gene regulation using tran-
scription factors.
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Introduction
A transcription factor is known as a regulator that localizes
into the nucleus and controls gene expression by binding to
specific DNA sequences (Boulikas 1994). Since the genera-
tion of induced pluripotent stem cells (iPSCs) using four de-
fined transcription factors (Oct4, Sox2, c-Myc, and Klf4),
many have taken an interest because transcription factors have
clinical significance as a therapeutic gene modulator
(Takahashi et al. 2007; Takahashi and Yamanaka 2006).
Defined transcription factors, which are delivered by viral
vectors, can induce somatic cells into becoming pluripotent
stem cells. However, a virus-based approach may cause tu-
morigenicity due to integration into the host cell genome
(Maherali and Hochedlinger 2008). As a solution, there have
been many trials to evade viral transduction by using
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nonintegrating plasmids (Chou et al. 2011). PiggyBac trans-
posons (Woltjen et al. 2009). and small-molecule compounds
(Hou et al. 2013). Although plasmids and transposons can
reduce the risks, they still have potency for genomic integra-
tion. Besides, molecule compounds were able to reprogram
mouse cells but were insufficient in reprograming human
cells. Thus, a protein-based approach is a practical method
for clinical use that can limit safety risks and has many
advantages (Cho et al. 2010; Kim et al. 2009). For
example, neuronal precursor cells (NPCs) derived from
protein-based iPSCs showed high expansion, whereas
NPCs from virus-based iPSCs exhibited early senes-
cence and apoptosis (Rhee et al. 2011).
There were many trials to express transcription factors as
recombinant proteins for the exploration of their mechanisms
and the application as clinical drugs (Mossakowska 1998).
Escherichia coli (E. coli) has been used commonly for the
production of recombinant proteins due to its high productiv-
ity, low production cost, and ease of product isolation
(Sorensen and Mortensen 2005). However, there are some
technical bottlenecks in the production of transcription factor
from E. coli. For instance, the recombinant proteins are
expressed as aggregate forms in many cases. As a result, it
requires additional solubilization and refolding steps which
increases production cost and decreases yield (Chan et al.
2013; Dyson et al. 2004). In addition, there is the risk that
the protein may lose the original bioactivity after the refolding
process (Chang et al. 2014; Smialowski et al. 2007). Methods
to increase solubility have been reported by optimizing E. coli
culture conditions (Yang et al. 2009) or through the use of a
buffer system (Golovanov et al. 2004).
In addition to the production of transcription factors, cell-
penetrating peptides (CPPs) are required for the intracellular
delivery of recombinant transcription factors, and many re-
searchers have used various CPPs, such as TAT (Frankel and
Pabo 1988). Antp (Perez et al. 1992). and poly-arginine (El-
Sayed et al. 2009). TAT was reported to have a higher bioac-
tivity than others (Zhang et al. 2012). however, there is a
limitation for clinical applications, as TAT is an HIV virus-
derived cell-penetrating peptide. Many CPPs have been used
only for delivery, and they did not affect transcription factors
for soluble expression or stability. Therefore, most transcrip-
tion factors with CPPs were expressed as an inclusion body
from E. coli making the purification process difficult or caus-
ing the loss of bioactivity (Yang et al. 2009).
In our previous study, we introduced silkworm hemolymph
(SH) as a substitute for fetal bovine serum (Ha et al. 1996) and
reported that SH increased host cell longevity (Ha and Park
1997). Purified 30K proteins from SH had an interesting role
in inhibiting apoptosis in various cells (Choi et al. 2002; Kim
et al. 2003; Kim and Park 2003; Kim et al. 2001; Kim et al.
2004; Park et al. 2003; Rhee et al. 1999; Rhee et al. 2002;
Rhee and Park 2000). The most abundant component among
30K proteins, 30Kc19 protein, delivered protein cargos into
cells (Park et al. 2012a, 2014b) by a dimerization mechanism
(Park et al. 2014a) and enhanced enzyme stability (Park et al.
2015; Park et al. 2012b). Furthermore, 30Kc19 protein and
human serum albumin nanoparticles were generated and suc-
cessfully delivered enzyme into cells or organs with low cy-
totoxicity (Lee et al. 2014). Here, we have used 30Kc19 cell-
penetrating protein as a novel fusion partner of transcription
factors which can be used in protein-based iPSC generation.
We anticipate that a 30Kc19 protein could deliver a transcrip-
tion factor into cells and also solve problems that normally
arise in the production of transcription factors, such as low
soluble expression and protein instability (Singh and Panda
2005). Thus, we propose that the multifunctional properties of
30Kc19 protein can be applied to general transcription factors
and overcome several hurdles when used as recombinant
proteins.
Materials and methods
Plasmid construction and protein expression
The 30Kc19 gene was constructed using Bombyx mori total
RNA (Kim et al. 2001) and amplified by polymerase chain
reaction (PCR). PCR product was inserted into a pET-23a
vector (Novagen, Madison, WI, USA) at EcoR1 and Xho1
site. Five transcription factors including Oct4 (Addgene plas-
mid # 17217), Sox2 (Addgene plasmid # 17218), c-Myc
(Addgene plasmid # 17220), Klf4 (Addgene plasmid #
17219), and L-Myc (Addgene plasmid # 26022) were also
inserted into the vector at BamH1, EcoR1. Each vector was
designed with a T7 tag at the N-terminus for immunoassay
and His tag at the C-terminus for purification. Each vector was
transformed to E. coli BL21 (Novagen), and cells were cul-
tured in LB medium with 100 μg/ml ampicillin. When OD600
reached 0.6 at 37 °C, isopropyl-β-D-thiogalactopyranoside
(IPTG) was added to a final concentration of 1 mM. For pro-
tein expression, the cells were further incubated at 27 or 37 °C.
Protein purification by fast protein liquid
chromatography
Harvested cells were disrupted by ultra-sonication in a lysis
buffer (20 mM Tris-HCl, 0.5 M NaCl, 20 mM imidazole, pH
8.0) and separated by centrifugation (12,000 rpm). The solu-
ble proteins in the supernatant were collected and loaded on a
HisTrap HP column (GE Healthcare, Uppsala, Sweden) using
FPLC (GE Healthcare). The washing buffer (20 mM Tris-
HCl, 0.5 M NaCl, 50 mM imidazole, pH 8.0) was placed into
the column to remove unbound proteins. Finally, target pro-
teins were eluted with the elution buffer (20 mM Tris-HCl,
0.5 M NaCl, 350 mM imidazole, pH 8.0) and dialyzed against
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Dulbecco’s modified eagle medium (DMEM, Gibco,
Invitrogen, Carlsbad, CA, USA).
Western blot analysis
Soluble transcription factors were analyzed using soluble frac-
tion in E. coli lysate. To check the stability of soluble proteins,
seven proteins (Oct4-30Kc19, Sox2-30Kc19, Klf4-30Kc19,
Sox2, Klf4, Sox2-R9, and Klf4-R9) were purified and incu-
bated at 37 °C. The samples were separated thru 10 % sodium
dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-
PAGE) and transferred onto a polyvinylidene difluoride
(PVDF) membrane (GE Healthcare). The membranes were
blocked with 5 % skim milk in TBS with 0.1 % tween 20.
Anti-T7 primary antibody (Abcam, Cambridge, UK) and anti-
rabbit horseradish peroxidase (HRP)-conjugated secondary
antibody (Millipore, Bedford, MA, USA) were used for im-
munoblot analysis. Luminata Forte Western HRP Substrate
(Millipore) was used as substrate of HRP. The band was visu-
alized by G:BOX Chemi XL system (Syngene, Cambridge,
UK), and the band intensities were quantified using ImageJ
software.
Live cell imaging and immunofluorescence microscopy
For live cell imaging assay, recombinant proteins were labeled
with an Alexa Fluor® 488 protein labeling kit (Invitrogen)
according to the manufacturer’s instructions. Human dermal
fibroblast (HDF, ATCC # PCS-201-010) cells were treated
with 20 μg/ml of labeled proteins. For immunofluorescence
assay, anti-T7 primary antibody (1:200) and anti-rabbit Alexa
488 or 594-conjugated secondary antibody (1:400) were used
on cells after treatment with 10μg/ml of protein for 24 or 48 h.
Hoechst 33342 (Life Technologies, Gaithersburg, MD) was
stained on nucleus and observed using confocal microscopy
(Olympus, Lake Success, NY, USA).
Luciferase assay
pGL3-Klf4 reporter plasmid and pRL-SV40 (Addgene plas-
mid # 27163) were delivered into HEK293 cells using
Lipofectamine® 3000 reagent (Invitrogen) according to the
manufacturer’s instructions. One day after the transfection,
cells were treated with proteins. A Dual-Glo® luciferase assay
system (Promega, Madison, WI, USA) was used for measure-
ment of luciferase. On a 96-well plate (Nunc Lab-Tek,
Thermo Scientific, Rockford, IL, USA), the cells were treated
with proteins for 4 h and then washed with DMEM. Twenty
microliters of a lysis reagent was added in 20 μl of DMEM
medium. After 10 min of incubation, the firefly luminescence
was measured using Luminometer (Thermo Scientific). Then
20 μl of stop reagent was added before measurement. The
ratio of Firefly/Renilla luminescence was calculated, and each
well was normalized from a control well.
Cell viability assay
To assess the toxicity of 30Kc19-conjugated protein, HDF
cells were treated with proteins (Oct4-30Kc19, Sox2-
30Kc19, c-Myc-30Kc19, and Klf4-30Kc19) in a 96-well
plate. The same concentrations of each protein, 2, 5, 10, and
15 μg/ml (total protein 8, 20, 40, and 60 μg/ml) were added
for 12 or 24 h. After treatment, cells were washed three times
with PBS and treated with MTT solution for 4 h then solubi-
lized for 12 h at 37 °C. Absorbance at 420 nm was measured
for the determination of cell viability.
Results
Soluble expression and purification of transcription
factors
Five transcription factors (Oct4, Sox2, c-Myc, Klf4, and L-
Myc) were selected as they are most popular regulators and
have been extensively studied since after the discovery of
iPSCs (Takahashi and Yamanaka 2006). We assumed that a
30Kc19 cell-penetrating protein would be a good strategic
fusion partner for unstable transcription factors. That is, a
30Kc19 protein can simultaneously enhance soluble expres-
sion, increase stability, and enhance delivery of transcription
factors into cells (Fig. 1).
First of all, the effect of 30Kc19 protein conjugation to
transcription factors on soluble expression was determined
(Fig. 2). Transcription factors were cloned in the pET-23a
vector for recombinant protein expression in E. coli. Each
factor was comprised with a T7 tag at the N-terminus for
immunoassay and a His tag at the C-terminus for purification
using affinity chromatography (Fig. 2a). For the delivery of
protein into cells, each factor was fused with nine-arginine
(R9) or 30Kc19. Transcription factor alone or with 30Kc19
was expressed in E. coli, and the lysates were separated into
soluble and insoluble fractions. Total lysate and soluble frac-
tion were then analyzed by SDS-PAGE and Western blot. In
previous studies, most transcription factors were demonstrated
to have poor solubility and require a solubilization process
(Hu et al. 2012; Pan et al. 2010; Zhang et al. 2012; Zhou et
al. 2009). When Oct4 alone was expressed, it was expressed
mainly as an inclusion body, and the level of soluble form was
extremely low (Fig. 2b). Interestingly, a considerable amount
of Oct4 conjugated with 30Kc19 protein was expressed in
soluble fraction, meaning that 30Kc19 protein enhanced sol-
uble expression. For Sox2 and Klf4, we observed that some of
those transcription factors were expressed as soluble proteins
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in our expression system as shown in Fig. 2b. The relative
protein expression level of each protein is shown in Fig. 2c.
To assess the effect of CPPs (R9 and 30Kc19) on
soluble expression, transcription factors conjugated with
R9 or 30Kc19 were expressed at 27 or 37 °C and the
soluble fraction of each protein was analyzed by
Western blot. As shown in Fig. 2d, 30Kc19 promoted
the production of Oct4 more as a soluble protein when
expressed at either 27 or 37 °C, while R9 did not in-
fluence Oct4 solubilization. In accordance with Fig. 2d,
Sox2 and Klf4 were expressed as soluble proteins re-
gardless of CPP type. While c-Myc was expressed as
insoluble protein in any situation (Fig. S1), another Myc
family member, L-Myc (Nakagawa et al. 2008;
Nakagawa et al. 2010). was highly expressed as a sol-
uble protein when it was fused with 30Kc19 protein,
whereas L-Myc alone showed a lower expression level
and was not produced in soluble form (Fig. S2a). With
R9, a small amount of L-Myc was expressed as soluble
protein at 27 °C (Fig. S2b). Overall, these results dem-
onstrate that 30Kc19 protein enhanced the soluble ex-
pression of Oct4, Sox2, and L-Myc, which became 7.0,
2.9, and 23.8 times its original amount, respectively.
To further explore the role of the 30Kc19 protein
conjugation on recombinant transcription factors, soluble
transcription factors were purified using affinity chroma-
tography. The size and amount of purified soluble pro-
teins were confirmed by Coommasie blue staining
(Fig. 3a) or Western blot (Fig. 3b). As shown in
Fig. 3, each of the purified proteins was confirmed for
their proper size. The results of purified Oct4 alone are
not shown as there was insufficient amount of original
soluble Oct4 as mentioned in Fig. 2. The amounts of
purified soluble Sox2 and Klf4, without any conjuga-
tions, were also low. In contrast, a relatively high level
of purified soluble Oct4-30Kc19, Sox2-30Kc19, and
Klf4-30Kc19 was observed, which coincides with the
results in Fig. 2 (Fig. 3a, b).
In vitro stability of soluble transcription factors
The stability of transcription factors is important for
effective gene regulation during cell culture. Here, we
have investigated if 30Kc19 protein conjugation contrib-
utes to the stability of transcription factors. To test the
effect of 30Kc19 protein on the stability of soluble tran-
scription factors in solution, seven purified soluble tran-
scription factors (Oct4-30Kc19, Sox2, Sox2-R9, Sox2-
30Kc19, Klf4, Klf4-R9, and Klf4-30Kc19) were added
and incubated in the culture medium. Oct4 alone and
Oct4-R9 were ruled out as they were expressed as an
inclusion body resulting in negligible amount of soluble
proteins. In serum-free medium, 10–15 μg/ml of puri-
fied soluble transcription factors were incubated at
37 °C for 24 or 48 h before analysis. By using
30Kc19 protein as a fusion partner for transcription fac-
tors, we found that the stability of the soluble transcrip-
tion factors was significantly increased (Fig. 4). The
levels of Sox2 and Klf4 proteins produced alone or with
R9 drastically decreased even within 24 h of incubation
Fig. 1 A schematic illustration of gene regulation by transcription factor-conjugated 30Kc19 protein
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in medium, indicating poor stability (Fig. 4b, c). In
contrast, all the transcription factors conjugated with
30Kc19 protein were stable for 48 h of incubation.
Thus, it is conclusive that the conjugation of 30Kc19
protein enhanced the stability of transcription factors in
the medium.
Cell penetration, intracellular stability, and cytotoxicity
of soluble transcription factors
In our previous work, 30Kc19 protein delivered cargo
protein into various cells and organs with maintaining
its stability and causing low cytotoxicity (Park et al.
Fig. 2 Plasmid construction and
soluble expression of
transcription factors. a
Transcription factors (Oct4, Sox2,
c-Myc, Klf4, and L-Myc) were
developed with and without nine-
arginine (R9) or 30Kc19. b
Comparison of soluble expression
between transcription factors
alone and transcription factors-
30Kc19 at 37 °C. E. coli lysates
were analyzed by Western blot. T
total lysate, S soluble fraction. c
The immunoreactive band
intensities were quantified using
ImageJ. d The effect of a CPP for
solubilization of transcription
factors at 27 and 37 °C. Soluble
fractions were analyzed by
Western blot. The arrows indicate
soluble target proteins
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2012a). Thus, the 30Kc19-conjugated transcription fac-
tors were selected for further study based on the follow-
ing expectations: enhanced intracellular delivery and sta-
bility, and low cytotoxicity. First, the cell-penetration
property of soluble transcription factors with 30Kc19
proteins was observed. To monitor the penetration of
transcription factors into HDF cells, the proteins were
labeled with Alexa Fluor® 488 and added to a culture
medium at 20 μg/ml of the concentration. The fluores-
cence was observed in a live cell image using confocal
microscopy. As shown in Fig. 5a, the transcription fac-
tor with the 30Kc19 protein was observed in the cells
within 30 min of incubation, and its intracellular con-
centration gradually increased over time. This indicates
that 30Kc19 protein conjugation successfully delivered
transcription factors into cells.
To confirm how long 30Kc19-conjugated transcrip-
tion factors remain in the cells, intracellular stability
was observed by immunofluorescence analysis. We
added 10 μg/ml of transcription factors to HDF cells
Fig. 3 SDS-PAGE and Western blot analysis of purified soluble
transcription factors. Soluble transcription factors were purified using
affinity chromatography. Purified proteins were separated by SDS-
PAGE then visualized using Coommasie blue staining (a) or Western
blot (b). The arrows indicate target proteins
Fig. 4 In vitro stability of soluble transcription factors. a Purified Oct4-
30Kc19 soluble protein was incubated in serum-free media at 37 °C and
analyzed using Western blot. The results of Oct4 alone and Oct4-R9 are
not shown as they were expressed as aggregate forms. b, c Purified Sox2
and Klf4 soluble protein were incubated with and without CPPs in serum-
free media at 37 °C. After incubation for the indicated periods of time, the
protein was analyzed by Western blot. Note that 30Kc19-conjugated
transcription factors remained intact even at 48 h of incubation
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for 24 and 48 h, respectively, and then the delivered
proteins in the cells were detected with immunofluores-
cence. As shown in Fig. 5b, 30Kc19-conjugated tran-
scription factors appeared to be stable inside the cells
for up to 48 h. These results show that 30Kc19-
conjugated transcription factors were stable in the cells
and also agree with the in vitro results
Subsequently, we evaluated if 30Kc19-conjugated
transcription factor has cytotoxicity. HDF cells were
treated with the same concentration of four conjugated
transcription factors simultaneously for 12 and 24 h in a
dose-dependent manner, and then cell viabilities were
assessed using MTT assay (Fig. S3). The concentration
of each protein was 2, 5, 10, and 15 μg/ml, respective-
ly. Even when the cells were treated with 60 μg/ml of
four conjugated transcription factors (15 μg/ml each),
there was no decrease in cell viability, meaning that
30Kc19-conjugated transcription factors have low
cytotoxicity.
Transcriptional activity of 30Kc19-conjugated Klf4
Once introduced into cells, a transcription factor binds
to its target DNA sequence in the nucleus for the con-
trol of transcription. Thus, we tested the transcriptional
activity of a transcription factor-conjugated with
30Kc19 protein compared with that conjugated with
R9. Among transcription factors, Klf4 protein was cho-
sen to confirm whether our recombinant proteins have
transcriptional activity in the cells. When cells were
treated with Klf4-30Kc19 protein, luciferase activity
increased significantly depending on the concentration
(Fig. 6a). Then, the transcriptional activity of Klf4-
conjugated with 30Kc19 or R9 was compared. One
Fig. 5 Intracellular penetration and long-term stability of 30Kc19-
conjugated soluble transcription factors. a Proteins were labeled with
Alexa Fluor 488 (green) for live cell imaging of 30Kc19-conjugated
transcription factors (Oct4, Sox2, and Klf4). HDF cells were treated
with labeled proteins in a time-dependent manner and detected using
confocal microscopy. b Intracellular proteins after incubation were
analyzed by immunofluorescence. Alexa Fluor 594 (red) antibody for
target proteins was used for the detection of transcription factors in the
cells. Nuclei were visualized by Hoechst (blue)
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micrograms per milliliter of each transcription factor
was delivered, and transcriptional activities were mea-
sured 4 and 24 h after delivery. Klf4-30Kc19 increased
transcriptional activity (p<0.05) as time progressed
(Fig. 6b). In contrast, there was no significant increase
in transcriptional activity of Klf4-R9 (p=nonsignifi-
cant; NS). We can hypothesize that the higher tran-
scriptional activity of Klf4-30Kc19 was due to the in-
creased intracellular stability of Klf4 through 30Kc19
conjugation. Immunocytochemistry of intracellular
Klf4-30Kc19 and Klf4-R9 showed that Klf4-R9 level
in cells drastically decreased from 4 to 24 h after de-
livery (Fig. 6c). In contrast, there was a considerable
amount of Klf4-30Kc19 still in the cells even at 24 h
after delivery. This observation was similar to the in
vitro stability results shown in Fig. 4. Thus, it is ob-
vious that 30Kc19 conjugation enhanced transcriptional
activity by increasing the intracellular stability of a
transcription factor.
Discussion
In this study, 30Kc19 protein was applied as a fusion
partner for the production of recombinant transcription
factors that are used for the generation of iPSCs. It was
hypothesized that the 30Kc19 protein has the potential
to be developed as a fusion partner in the protein-based
delivery of transcription factors for the regulation of
gene expression, as it was shown to enhance the intra-
cellular delivery as well as stability of its fusion protein.
Interestingly, we have also found that the C-terminal
fusion of the 30Kc19 protein promoted the soluble pro-
duction of transcription factors, especially for Oct4 and
L-Myc, while R9 did not. In fusion technology, fusion
partners such as such as MBP, Trx, and NusA
(Vincentelli et al. 2011) are usually added at the N-
terminus to express soluble proteins (Sorensen and
Mortensen 2005). However, because the N-terminus re-
gion of most transcription factors is important for their
Fig. 6 Effect of 30Kc19 conjugation on intracellular transcriptional
activity of Klf4 protein. a Klf4-30Kc19 protein was delivered into
transfected cells, and luciferase activity was measured after 4 h to
determine transcriptional activity. b One micrograms per milliliter of
Klf4-R9 or Klf4-30Kc19 proteins were added to cells. Luciferase
activity of Klf4 was measured after 4 or 24 h incubation, respectively
(*p<0.05; **p<0.005; ***p<0.0005; NS nonsignificant). c Delivered
Klf4 protein with 30Kc19 or R9 was analyzed by immunofluorescence.
Green fluorescence represents the amount of Klf4 protein in the cells.
Bright field (BF) images and fluorescence of nuclei (blue) images were
merged and shown in the left panel. The numbers indicate the time of
incubation
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functionality, in many cases, those typical fusion part-
ners cannot be used. Unlike others, 30Kc19 protein can
be placed at the C-terminus of target protein and in-
creases solubility. Thus, the 30Kc19 protein is an eligi-
ble fusion partner for soluble expression of transcription
factors.
Even though the recombinant proteins were produced
as soluble forms, the extracellular and intracellular in-
stabilities of these proteins after treatment are a critical
problem still requiring a solution. It was reported that
unstable soluble proteins are aggregated easily during
cell culture (Sorensen and Mortensen 2005). There were
trials to increase the stability of proteins by adding sup-
plements such as lipid-rich albumin or serum (Thier et
al. 2010; Thier et al. 2012). We observed that 30Kc19-
conjugated transcription factors showed enhanced stabil-
ity without additive materials to a culture medium.
Previously, we reported that 30Kc19 protein increased
enzyme stability via shielding effect; possibly by hydro-
phobic interaction (Park et al. 2012b). The increased
stability of transcription factor is also considered to be
due to the shielding effect of 30Kc19 protein. From
luciferase and immunofluorescence assay, the results in-
dicate that 30Kc19-conjugated with transcription factors
enhances the intracellular stability of the protein and
thus provides more opportunities for the transcription
factor to further penetrate into the nucleus to carry out
its role in binding to target DNA to participate in tran-
scription. To accomplish successful protein-based
reprogramming, a significant amount of proteins is re-
quired (Yang et al. 2009). However, because of a cyto-
toxicity hurdle, a small number of proteins (0.5–8 μg/
ml) had to be added repeatedly, and 36 h was required
between the cycles (Zhou et al. 2009). In the case of
the 30Kc19-conjugated protein, even when the concen-
tration of total proteins was 60 μg/ml, statistical differ-
ences in cytotoxicity were not observed. This demon-
strates that 30Kc19 protein is a nontoxic carrier for
the delivery of transcription factors and enhances that
stability of adjacent proteins.
Protein-based delivery of transcription factors can be
applied in many ways. Similar to iPSC generation, for
direct lineage reprogramming that induces somatic cells
into becoming a specialized cell type, defined transcrip-
tion factors are required (Xu et al. 2015). Additionally,
the nuclear receptors which are classified as transcrip-
tion factors are potential drug candidates. These are re-
lated to metabolic diseases including cancer, infertility,
obesity, and diabetes as potential drug candidates
(Gronemeyer et al. 2004). In the use of transcription
factors, protein can be an alternative method to avoid
genomic integration that is possible with a conventional
virus method. In this article, we have shown that a
30Kc19 cell-penetrating protein simultaneously enhances
soluble expression, stability, and the transcriptional ac-
tivity of transcription factors. Therefore, we propose that
conjugation with the 30Kc19 protein is a novel ap-
proach that addresses the technical bottlenecks of gene
regulation using transcription factors.
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